Analysis reveals psoriasis management involves symptom control in diverse populations, suggesting the need for ongoing care.
Psoriasis is a chronic, immune-mediated inflammatory skin disease with a relapsing-remitting course, affecting 1–3% of the population. Chronic plaque psoriasis is the most common form. Symptoms such as scaling and itching can impair quality of life. Management focuses on symptom control using topical and systemic therapies. Associated comorbidities and unpredictable progression highlight the need for ongoing, patient-centred care and research.
No takes yet. Share an insight, caveat, or question.
Margaret Perry (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: